Marvell Plans Merger with Lumentum: A Case for Optical and Electronic Co-Design, with Competitive Advantages Still to Be Realized

The Deal Has Been Announced; Integration Has Yet to Happen

Marvell and Lumentum announced their proposed merger on November 2, with the agreement signed on November 1. Each eligible share of Lumentum common stock will be exchanged for 4.5 shares of Marvell common stock. The announcement’s implied enterprise value of $115 billion was calculated using reference share prices from October 28. The exchange ratio is fixed, but the reference value remains subject to share price movements. The companies expect to close in the first half of calendar 2028, subject to approval by both companies’ shareholders, regulatory approvals and other conditions. Any discussion of the integration’s impact must begin with the premise that the transaction has not yet closed.

Evidence: [2] [3] [1]

How the Components Are Designed Together Deserves Attention

On the joint call, management grounded the integration rationale in an architectural shift that brings optical connections closer to compute engines, identifying scale-up and scale-in as long-term directions. Marvell contributes capabilities including DSPs, TIAs, drivers and silicon photonics; Lumentum contributes light sources, modulators, detectors and some transceiver modules. This suggests that the merger’s potential value lies in bringing electronic chips and optical components into co-design earlier, so that product choices on each side can work together. That explains why complementary capabilities could be useful. The call did not provide independently measured power-consumption benefits or customer adoption shares; the technical value still needs to be demonstrated through product and deployment results.

Evidence: [6]

Growth Has Materialized; Order Commitments Still Carry Fulfillment Risks

In the first quarter of fiscal 2027, ended September 26, 2026, Lumentum reported revenue of $1.2626 billion, up 136.5% year over year and 25.5% sequentially, showing that its business has already achieved substantial growth. In these unaudited quarterly results, the GAAP operating margin was 28.5%, while the non-GAAP operating margin was 42.3%; that distinction must be retained when discussing profitability. The company also disclosed a second major NPO/CPO program backed by purchase commitments exceeding $5 billion. These commitments indicate customer demand intentions, but the announcement lists risks of order cancellations, reductions and delays, as well as risks related to production capacity and delivery. They therefore cannot establish that revenue or cash is already secured.

Evidence: [4] [5]

The Reference Price Requires Growth to Keep Materializing

The $115 billion reference enterprise value is about 18 times the $6.4 billion obtained by annualizing the midpoint of next quarter’s revenue guidance. This comparison relies on quarterly revenue guidance of $1.575–1.625 billion and extends a single quarter’s level across a full year, so it provides only a rough measure for assessing the transaction’s pricing. My judgment is that this reference price requires continued support from subsequent growth and profitability. The reported quarterly growth helps explain the market’s interest in Lumentum, but cannot by itself establish that the transaction price is reasonable. In particular, annualized guidance must not be treated as realized full-year revenue.

Evidence: [1] [4]

Supply Relationships Cannot Yet Be Assumed to Form a Closed Platform

Management explicitly stated that it plans to maintain the existing go-to-market model and continue supplying components and systems across the ecosystem. On that basis, co-design after the merger and sales to external customers can coexist. At this stage, concluding that outside suppliers will be excluded or that competitors have already lost orders goes beyond what the disclosures support. The more useful questions are how extensively customers will adopt jointly designed products and how much choice they will retain to source independently. Those choices will determine whether complementary capabilities translate into commercial advantages. Actual purchasing outcomes are still lacking.

Evidence: [6]

The Thesis Ultimately Depends on Delivery and Costs

The companies expect more than $1 billion in annual run-rate cost synergies, primarily from cost of sales, and expect the transaction to be accretive to non-GAAP EPS in the first year after closing. These are forward-looking targets. Taken together, the current disclosures lead me to conclude that the proposed merger has a clear rationale based on complementary products, while the assessment of competitive advantage should remain open. If jointly developed products win customer adoption, purchase commitments are fulfilled on schedule and cost synergies can be clearly accounted for in reported results, the integration’s value will have stronger support. If deliveries are delayed, customers reduce orders or synergies prove difficult to realize, expectations will need to be lowered. Expected EPS accretion alone also does not imply a rise in the share price.

Evidence: [6] [1] [5]

What to watch next

• Whether shareholder and regulatory approvals progress, and whether the expected closing timeline changes.
• Arrangements for fulfilling NPO/CPO purchase commitments, and whether subsequent disclosures report cancellations, reductions or delays.
• Whether disclosures on jointly designed products include actual customer adoption, deployment outcomes and comparable performance results.
• Whether the companies continue supplying the broader ecosystem, and how cost synergies appear in subsequent results.